Search

Filter By:

Life Sciences Industry Outlook 2026 

The Life Sciences Industry Outlook 2026 examines key trends shaping biotech, medtech, and pharma, from precision medicine and digital trials to funding, manufacturing, and regulatory change.

Learn More

R&D Tax Strategy for Life Sciences companies

Life Sciences companies face growing R&D challenges and costs. Learn how your organization can leverage U.S. and international tax credits to support innovation and reduce expenses.

Learn More

Mastering Gross-to-Net (GTN) Challenges in Life Sciences: A Pathway to Success

Life science companies face complex gross-to-net (GTN) challenges, from managing rebates and pricing to ensuring compliance and accurate forecasts. Learn how a strategic approach and support can drive clarity and success.

Learn More

Life Science Outlook 2025: Navigating Transformation in a Complex Landscape

The life sciences sector stands at a pivotal moment of transformation, driven by technological breakthroughs, evolving market dynamics and shifting …

Learn More

Key Policy Changes Impacting the Life Sciences Industry

The life science industry stands at a pivotal moment as it anticipates potential shifts in federal policy. With the Trump …

Learn More

Life science companies are a target for cybercriminals: Building effective cyber governance is imperative

Cyber risk continues to be a major concern for businesses of all kinds, including life science companies. Not only can …

Learn More

Three strategies for lowering your tax liability under the new R&D tax rules

For tax years ending December 31, 2021 and prior, companies could deduct their entire research and development (R&D) costs on …

Learn More